Last reviewed · How we verify
Trial of Magnesium Supplementation and Blood Pressure Reduction Among Adults With Elevated Systolic Blood Pressure
The purpose of this study is to assess whether 480 mg/day magnesium glycinate supplementation for 12 weeks lowers blood pressure.
Details
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Phase | NA |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 120 |
| Start date | 2023-01-17 |
| Completion | 2026-05 |
Conditions
- Blood Pressure
Interventions
- magnesium glycinate supplement
- placebo
Primary outcomes
- Change in seated systolic blood pressure from baseline to 12 weeks — Baseline and 12 week
- Change in seated diastolic blood pressure from baseline to 12 weeks — Baseline and 12 week
Countries
United States